Ziegler Capital Management’s Cardlytics CDLX Stock Holding History

Ziegler Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,577	Closed	-$7.99M	–	429
2021 Q2	$7.99M	Sell	2,577 -3,832	-60%	-$4.32M	0.27%	136
2021 Q1	$7.03M	Sell	6,409 -118	-2%	-$156K	0.22%	157
2020 Q4	$9.32M	Sell	6,527 -2,541	-28%	-$2.71M	0.31%	122
2020 Q3	$6.4M	Sell	9,068 -203	-2%	-$148K	0.25%	150
2020 Q2	$6.49M	Buy	9,271 +2,498	+37%	+$1.44M	0.21%	163
2020 Q1	$2.37M	Buy	+6,773	New	+$4.8M	0.06%	277

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Ziegler Capital Management's CDLX Position: Q3 2021 in Review

Ziegler Capital Management sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 2,577 shares — an estimated $7.99M sold.

Ziegler Capital Management first reported a position in CDLX in Q1 2020 and held it in 6 quarters. The position peaked at $9.32M in Q4 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

Ziegler Capital Management reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
Ziegler Capital Management sold 2,577 Cardlytics shares in Q3 2021, an estimated $7.99M.
Ziegler Capital Management first reported a position in Cardlytics in Q1 2020 and held it in 6 quarters.
Ziegler Capital Management's Cardlytics position peaked at $9.32M in Q4 2020.
164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Ziegler Capital Management's 13F filing for Q3 2021, filed 27 Oct 2021.